Venture fundraising dedicated to healthcare continues to rise
Fueled by venture healthcare’s rapid response to the pandemic, venture capital fundraising boomed in 1H 2021 to $21.8B, exceeding the full-year venture healthcare record in 2020 ($16.8B) by 30%.
Private investments led by healthtech and biopharma
Q1 2021 spiked to a record $23.4B, beating Q3 2020’s quarterly record by 56%. This aggressive activity continued into Q2 2021, increasing to $23.9B. Total healthcare investment dollars in 1H 2021 hit $47B, more than double 2020’s first half pace.
IPO activity is up, but post-IPO performance is waning
The number of venture healthcare IPOs in 1H 2021 (81) was close to 2020’s full-year pace (111). Post-IPO performance for the class of 2021, however, has been mixed, with good performance for dx/tools and device but lower for biopharma and healthtech.